Table 1.
TSH suppression targets for types I and II patients (unit: μIU/mL)
DTC recurrence risk | ||||
---|---|---|---|---|
1 year after operation | Follow-up period | |||
Medium & high | Low | Medium & high | Low | |
Side effect risk of TSH suppression | ||||
Medium & high | <0.1 | 0.5–1.0 | 0.1–0.5 | 1.0–2.0 |
Low | <0.1 | 0.1–0.5 | <0.1 | 0.5–2.0 |